Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects

Trial Profile

Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Jan 2015

At a glance

  • Drugs Eslicarbazepine acetate (Primary) ; Simvastatin
  • Indications Diabetic cardiomyopathy; Hypercholesterolaemia; Hyperlipoproteinaemias; Hypertriglyceridaemia; Low HDL cholesterol; Multiple sclerosis; Neuropathic pain; Partial epilepsies
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Bial
  • Most Recent Events

    • 05 Dec 2011 Results presented at the 65th Annual Meeting of the American Epilepsy Society.
    • 07 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top